New Market Research Report: Mexico Pharmaceuticals & Healthcare Report Q2 2014
We identified Mexico as 'the most promising emerging pharmaceutical market' in September 2013, Shortly after this, the approval of the energy reform bill reinforced our view that, over the long term, healthier fiscal revenue will encourage the government to further increase public healthcare spending and improve national medical service standards. Multinational pharmaceutical companies will have more opportunities to fully capitalise on Mexico's strong pharmaceuticals and healthcare market growth.
View full press release